Popular Weight-Loss Drug Alli Recalled Due to Package Tampering

GlaxoSmithKline (GLAXF), the maker of the popular over the counter weight loss drug, Alli (pronounced AL-eye), is voluntarily recalling the diet pills from retailers’ shelves in the US and Puerto Rico because it believes some packages were tampered with and may contain products that are not authentic.

New York Alli recall lawyers reviewing new claims

If you have purchased a bottle that you believe may have been tampered with or have experienced negative side effects, drug interaction, or serious injury from Alli, immediately contact a New York product liability lawyer at Edelman, Krasin & Jaye to discuss your legal options and help you determine if you could be entitled to compensation.

The circumstances and motive behind the tampering are still a mystery. A GlaxoSmithKline spokesperson said that twenty tampered bottles of Alli were reported in Alabama, Florida, Louisiana, Mississippi, New York, North Carolina, and Texas. Twelve different customers reported the tampering.

At least 20 Alli bottles tampered with, according to reports

The company said that a range of tablets and capsules of various shapes and colors were found inside the Alli bottles. Some bottles inside the outer carton were missing the proper labels and had tamper-evident seals that were not authentic. GlaxoSmithKline described authentic Alli as a turquoise blue capsule with a dark blue band imprinted with the text “60 Orlistat,” the active compound that prevents the absorption of fat.  It’s packaged in a labeled bottle that has an inner foil seal imprinted with the words: “Sealed for Your Protection.”

GLAXF spokesperson Deborah Bolding said that the company had received no reports of serious illness from the consumers who reported the tampered products. She did not say if anyone had consumed the fake pills. GSK is conducting its own investigation into the tampering and is working with the Food and Drug Administration (FDA) on the Alli diet pill recall.

Alli is a non-prescription form of the drug Orlistat and prevents about 25% of ingested fat from being absorbed into the intestines. Obesity researcher Donna Ryan from the Pennington Biomedical Research Center in Baton Rouge said that the recall is a loss for patients who believe that Alli works for them to help them avoid high-fat meals and snacks.

From a physician’s perspective, Ryan said, “…this is the only over-the-counter medication that had evidence published in peer-reviewed journals to support efficacy and safety. There is four-year data to support this medication as being effective in preventing weight regain”.

“Safety is our first priority,” said GLAXF’s Bolding. “We want people to look at the Alli they have at home on their medicine shelf and make sure it’s authentic. If that product has in fact been tampered with, it will be part of the investigation.”

Alli is offered in a 60-milligram dose and is taken up to three times a day with meals. The Alli label says that for every five pounds a person loses on his or her own, Alli will increase that loss by another two to three pounds. Orlistat is sold in a larger dose by prescription as Xenical by Roche Holding AG.

Advice from a NY weight loss pill recall attorney

If you have suffered any negative side effects or drug interactions due to drug tampering, contact a New York Alli recall lawyer at 1-800-469-7429 to schedule a free case review. The attorneys at Edelman, Krasin & Jaye boast a long track record of successful product recall verdicts and settlements and are ready to discuss your legal options.